Does ABROCITINIB Cause Therapeutic product effect incomplete? 186 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 186 reports of Therapeutic product effect incomplete have been filed in association with ABROCITINIB (CIBINQO). This represents 5.9% of all adverse event reports for ABROCITINIB.
186
Reports of Therapeutic product effect incomplete with ABROCITINIB
5.9%
of all ABROCITINIB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From ABROCITINIB?
Of the 186 reports, 2 (1.1%) resulted in death, 4 (2.2%) required hospitalization.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABROCITINIB. However, 186 reports have been filed with the FAERS database.
What Other Side Effects Does ABROCITINIB Cause?
Drug ineffective (398)
Condition aggravated (316)
Off label use (269)
Pruritus (171)
Rash (134)
Nausea (130)
Dermatitis atopic (110)
Headache (85)
Acne (73)
Fatigue (70)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which ABROCITINIB Alternatives Have Lower Therapeutic product effect incomplete Risk?
ABROCITINIB vs ACALABRUTINIB
ABROCITINIB vs ACAMPROSATE
ABROCITINIB vs ACARBOSE
ABROCITINIB vs ACCUTANE
ABROCITINIB vs ACEBUTOLOL